HSP90AB1 and diffuse large B-cell lymphoma: The function of HSP90 and the impact of HSP90 inhibitors in the most popular kind of lymphoid malignancies, such as diffuse large B-cell lymphomas (DLBCL) that come from germinal center B-cells, remain largely unexplored and not well understood (Klein and Dalla-Favera, 2008).